Company Profile
PROCEPT BioRobotics Stock Price, News & Analysis
- Ticker:
- PRCT
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, PROCEPT BioRobotics is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
20.60 USD (-2.18%)
Close
Last updated: June 23, 2026 at 00:00
1.17B USD
Market cap
Why the stock is moving
PRCT is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
PROCEPT BioRobotics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, PROCEPT BioRobotics is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
PROCEPT BioRobotics follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, PROCEPT BioRobotics sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of PROCEPT BioRobotics (PRCT)?
PROCEPT BioRobotics (PRCT) most recently closed at 20.60 USD, a -2.18% move versus the previous session.
What is the market cap of PROCEPT BioRobotics (PRCT)?
PROCEPT BioRobotics currently has a market capitalization of 1.17B USD on BioPharmSignal.
What does PROCEPT BioRobotics do?
PROCEPT BioRobotics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is PRCT stock listed?
PROCEPT BioRobotics (PRCT) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, PROCEPT BioRobotics is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is BioRobotics?
PROCEPT BioRobotics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is PROCEPT BioRobotics targeting with BioRobotics?
PROCEPT BioRobotics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.